Association between anlotinib trough plasma concentration and treatment outcomes in advanced non-small-cell lung cancer

BACKGROUND: Efficacy and toxicities of anlotinib (ANL) show large inter-patient variation, which may partly be explained by differences in ANL exposure. Exposure-response/toxicities relationship have not been investigated for ANL. Therefore, the aim of the present study was to explore the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ling, Jiang, Hong, Rao, Jun-jie, Wang, Liu-sheng, Yan, Wei, Ye, Jian, Lou, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020721/
https://www.ncbi.nlm.nih.gov/pubmed/36937430
http://dx.doi.org/10.3389/fonc.2023.1146362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020721/
https://www.ncbi.nlm.nih.gov/pubmed/36937430
http://dx.doi.org/10.3389/fonc.2023.1146362

Ejemplares similares